Streptococcus Patents (Class 424/93.44)
-
Publication number: 20130071367Abstract: The present invention is directed to a animal feed for calves comprising calf-specific bacteria, optionally lipids, proteins, vitamins and/or mineral materials for conditioning of the intestinal flora in calves, and thus, for prophylaxis and/or treatment of diarrhea in calves.Type: ApplicationFiled: March 28, 2011Publication date: March 21, 2013Applicant: Technische Universitat MunchenInventors: Johann Bauer, Karin Schwaiger
-
Patent number: 8399238Abstract: The present invention relates to shelf-stable liquid products, for example diary products, comprising micro-organisms, especially probiotics. The micro-organisms are able to survive for several months at room temperature basically due to their inability to metabolise nutrients contained in the liquid product. The invention further relates to a method for manufacturing the liquid product according to the invention.Type: GrantFiled: March 23, 2005Date of Patent: March 19, 2013Assignee: Nestec S.A.Inventors: Sylvie Tournade, Frederic Aymes, Roberto Reniero
-
Patent number: 8377430Abstract: The invention relates to an infant formula comprising a source of protein in an amount of not more than 2.0 g/100 kcal, a source of lipids, a source of carbohydrate and a probiotic wherein the probiotic is present in an amount equivalent to between 102 and 105 cfu/g of dry formula. The invention further extends to the use of such an infant formula to modulate the immune system of a neonatal infant to promote the development in the first few weeks of the life of the infant of a beneficial intestinal microbiota comparable with that found in breast fed babies as well as to promote the maturation of the immune system of a neonatal infant in the first few weeks of life.Type: GrantFiled: April 10, 2006Date of Patent: February 19, 2013Assignee: Nestec S.A.Inventors: Anne Donnet-Hughes, Eduardo Schiffrin, Ferdinand Haschke, Marie-Claire Fichot, Karl-Josef Huber-Haag
-
Publication number: 20130004539Abstract: The invention provided herein relates to a method of preventing a Staphylococcus aureus colonization and/or infection by administering a Streptococcus pneumoniae strain, antigen thereof, or homologous staphylococcal antigen. The invention further relates to a method of treating a disease associated with a Staphylococcus aureus colonization and/or infection by administering a Streptococcus pneumoniae strain, antigen thereof, or homologous staphylococcal antigen.Type: ApplicationFiled: March 14, 2011Publication date: January 3, 2013Inventors: Jeffrey Weiser, Rebeccah S. Lijek
-
Publication number: 20120321709Abstract: Disclosed are a complex formulation for oral administration comprising probiotic formulation and 5-HT4 receptor agonist, and a method for the preparation thereof.Type: ApplicationFiled: February 25, 2011Publication date: December 20, 2012Applicant: HANMI SCIENCE CO LTDInventors: Jong Soo Woo, Jae Hyun Park, Yong Il Kim, Dong Ho Kim, Jun Young Choi
-
Publication number: 20120308524Abstract: The invention provides a composition for use in therapy of lactose intolerance or conditions arising from lactase deficiency, wherein the composition is a non-dairy solid dosage form comprising: (a) a lactase; and (b) one or more lactase-producing and/or lactase containing microorganisms selected from Lactobacillus delbrueckii ssp bulgaricus and Steptococcus thermophilus; wherein the lactase (a) is other than a lactase derived from the said one or more microorganisms (b); and wherein the one or more lactase-producing and/or lactase-containing microorganisms (b) are in dried form. Also provided are uncoated capsule and tablet compositions containing the lactase and the lactase-producing and/or lactase-containing microorganisms.Type: ApplicationFiled: February 4, 2011Publication date: December 6, 2012Applicant: Vitacare GmbH & Co. KGInventors: Daniel Henry Wyrobnik, Isaac Harry Wyrobnik
-
Patent number: 8324354Abstract: The invention relates to the field of the diagnosis of and vaccination against Streptococcal infections, and to the detection of virulence markers of Streptococci. The invention discloses a method for modulating virulence of a Streptococcus comprising modifying a genomic fragment of the Streptococcus, wherein the genomic fragment comprises at least a functional part of a fragment identifiable by hybridization in Streptococcus suis to a nucleic acid or fragment thereof.Type: GrantFiled: October 31, 2007Date of Patent: December 4, 2012Assignee: Stichting Dienst Landbouwkundig OnderzoekInventor: Hilda Elizabeth Smith
-
Publication number: 20120294839Abstract: Prosthetic apparatuses with probiotic microorganisms to control colonization of pathogenic bacteria are disclosed. The prosthetic apparatus may include a first portion having a first mating surface, a second portion having a second mating surface that conforms to the first mating surface, and at least one strain of probiotic microorganisms retained between the first and second mating surfaces prior to implantation of the prosthetic apparatus.Type: ApplicationFiled: February 24, 2012Publication date: November 22, 2012Applicant: ZIMMER DENTAL, INC.Inventor: John Zacharia
-
Publication number: 20120294840Abstract: The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.Type: ApplicationFiled: May 11, 2012Publication date: November 22, 2012Inventors: David S. Newburg, John M. McCoy, Massimo Merighi, Matthew Ian Heidtman, Zhuoteng Yu
-
Publication number: 20120288483Abstract: The disclosure relates to a solid glass matrix of polysaccharides, monossaccharides or disaccharides in combination with polyols as delivery vehicles for preservation and post gastric administration of a probiotic. The delivery vehicle is capable of releasing the probiotic at their site of action. The present invention further includes methods of making and using the solid glass matrix delivery vehicle of the invention.Type: ApplicationFiled: April 30, 2012Publication date: November 15, 2012Inventor: MORDECHI HAREL
-
Publication number: 20120282304Abstract: The present invention relates to multi-coated lactic acid bacteria coated with a multi-coating layer forming bacterial clusters and including protein, polysaccharide, and edible oil/fat component, and a preparing method thereof. The multi-coated lactic acid bacteria according to the present invention may achieve an improved acid resistance, a bile resistance, and an accelerated test stability, may have a low moisture content to be particularly stable against a moisture variation, and thus may be appropriately used to prepare various products including lactic acid bacteria.Type: ApplicationFiled: October 11, 2011Publication date: November 8, 2012Applicant: CELL BIOTECH CO., LTD.Inventor: Myung Jun Chung
-
Publication number: 20120247993Abstract: A probiotic composition including a probiotic microorganism embedded within a matrix, the matrix substantially maintaining the viability of said microorganisms. The matrix releases said microorganisms into and upon contact with a liquid carrier. The invention includes methods for manufacturing the composition, particular forms of the composition (2) and as apparatus for administration.Type: ApplicationFiled: November 13, 2009Publication date: October 4, 2012Applicant: UNISTRAW PATENT HOLDINGS LIMITEDInventors: Ken Palazzi, Mark Styan, Kristel Wallis, Jenni Sofjan, Yin Li, Patricia Conway
-
Publication number: 20120237489Abstract: A suppository is provided for rectal, vaginal or urethral administration. A method also is provided for the preparation of a suppository for rectal, vaginal or urethral administration. The method uses at least one unsaturated, non-esterified fatty acid in a composition containing a probiotic and an antibiotic.Type: ApplicationFiled: December 1, 2010Publication date: September 20, 2012Inventor: Bettina Heil
-
Patent number: 8257694Abstract: A nutritional composition for reducing oxidative damage and lipid peroxidation in humans, while allowing for the oxidative reactions necessary to sustain vital biological functions. The nutritional compositions comprise adaptogens comprising astragalus root, ashwagandha root, cordyceps, holy basil leaf, maca root, reishi mushrooms, schisandra, and suma root; superfoods comprising acerola, camu-camu, pomegranate, bilberry, blueberry, Goji berries, Acai, maitake, citrus bioflavonoids, rose hips, and Gingko biloba; probiotics comprising Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus acidophilus DDS-1, Lactobacillus bulgaricus, Lactobacillus casei, and Streptococcus thermophilus; and enzymes comprising amylase, papain, cellulase, lactase, lipase, protease, and bromelain. The nutritional compositions may also be provided as a meal replacement and further comprise one or more plant products, algae, vitamins, minerals, protein and methylsulfonylmethane (MSM).Type: GrantFiled: May 14, 2009Date of Patent: September 4, 2012Assignee: Product Partners, LLCInventors: Carl D. Daikeler, Isabelle B. Daikeler, Darin L. Olien
-
Patent number: 8257693Abstract: The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment.Type: GrantFiled: March 19, 2009Date of Patent: September 4, 2012Assignee: Kibow Biotech, Inc.Inventor: Natarajan Ranganathan
-
Publication number: 20120219526Abstract: The present invention relates to nutritional composition for infants and/or children comprising lactoferrin and probiotics. These compositions have been found to be useful in providing health benefits in infants and/or children. A method of manufacture of these compositions is also part of the invention. These compositions may be in the form of a kit of parts wherein a first composition according to the invention and a second composition according to the invention are each adapted to fulfil the nutritional requirements in two different age groups.Type: ApplicationFiled: October 29, 2010Publication date: August 30, 2012Applicant: Nestec S.A.Inventors: Petra Gerda Klassen, Corinne Magliola, Daniel Roland Manser, Theresa Voss
-
Publication number: 20120207726Abstract: The invention discloses biomarkers for human autism. The invention provides methods for treating, preventing, and diagnosing human autism and autism-related disorders.Type: ApplicationFiled: December 16, 2011Publication date: August 16, 2012Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKInventors: W. Ian Lipkin, Mady Hornig, Brent L. Williams
-
Publication number: 20120195867Abstract: The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding modules comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example.Type: ApplicationFiled: May 11, 2010Publication date: August 2, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120189597Abstract: Nutritional compositions and methods of making and using the nutritional compositions are provided. In a general embodiment, the present disclosure provides a nutritional composition including one or more exogenous nucleotides.Type: ApplicationFiled: August 9, 2010Publication date: July 26, 2012Applicant: NESTEC S.A.Inventors: Norman Alan Greenberg, Douglas Richard Bolster
-
Publication number: 20120189598Abstract: The present invention relates to the field of nutrition for children. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics.Type: ApplicationFiled: May 11, 2010Publication date: July 26, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120183515Abstract: The present invention relates to the field of nutrition. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics.Type: ApplicationFiled: May 11, 2010Publication date: July 19, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120183513Abstract: Isolated Lactobacillus strains are useful in preventing or delaying the development of Type 1 Diabetes (T1D). A probiotic composition comprising the Lactobacillus strains and use of the composition in T1D prevention are provided.Type: ApplicationFiled: February 18, 2010Publication date: July 19, 2012Inventors: Josef Neu, Graciela Liliana Lorca, Eric W. Triplett, Mark A. Atkinson, Desmond A. Schatz
-
Publication number: 20120183514Abstract: The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms.Type: ApplicationFiled: May 11, 2010Publication date: July 19, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120156171Abstract: The invention relates to a cosmetic and/or dermatological topical composition, of particular use for the preventional and/or treatment of sensitive and/or dry skin, comprising an effective amount of at least one particularly probiotic microorganism and/or a fraction or metabolite thereof in combination with an effective amount of at least one polyunsaturated fatty acid and/or polyunsaturated fatty acid ester and/or a salt or derivative thereof in a physiologically-acceptable vehicle.Type: ApplicationFiled: December 19, 2011Publication date: June 21, 2012Applicants: NESTEC S.A., L'OREALInventors: Lionel BRETON, Roland JOURDAIN, Audrey GUENICHE, Isabelle BUREAU-FRANZ, Mathilde FLEITH, Armand MALNOE
-
Publication number: 20120141443Abstract: The present invention generally relates to the field of bacteria. In particular, the present invention concerns “short time high temperature” treated probiotics and/or dairy starter cultures and applications of these bacteria. One embodiment of the present invention relates to “short-time high temperature” treated probiotics and/or dairy starter cultures and their use to prepare compositions to treat or prevent inflammatory disorders.Type: ApplicationFiled: May 7, 2010Publication date: June 7, 2012Applicant: NESTEC S.A.Inventors: Guenolee Prioult, Annick Mercenier
-
Publication number: 20120141444Abstract: The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding formulas for complete nutrition comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example.Type: ApplicationFiled: May 11, 2010Publication date: June 7, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120141445Abstract: The invention pertains to a composition for stimulating muscle strength in elderly, comprising whey protein, free BCAA and probiotic bacteria, wherein the composition comprises one or more free BCAAs selected from the group consisting of leucine, isoleucine and valine, and at least 50 g whey protein per 100 g dry weight of the total composition. Also, the invention pertains to a composition additionally comprising one or more dietary fibers selected from the group of pectins, pectates, alginates, fructans, fructooligosaccharides, indigestible dextrins, galactooligosaccharides, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides, mannooligosaccharides and fucooligosaccharides, and to the use of such composition in dietary management of malnutrition of elderly.Type: ApplicationFiled: June 7, 2010Publication date: June 7, 2012Inventors: Erwin Peke Meijer, Maarten Anne Hoijer
-
Patent number: 8192733Abstract: A probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium. The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the disclosure may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.Type: GrantFiled: July 20, 2010Date of Patent: June 5, 2012Assignee: Cobb & AssociatesInventors: Mark L. Cobb, Alyson Cobb
-
Publication number: 20120134973Abstract: The present invention relates to use of a probiotic to normalize abnormal inflammation markers. The present invention also relates to use of a probiotic for preventing and/or treating low-grade inflammation. Further, the present invention relates to use of a probiotic for preventing and/or treating disorders and/or diseases relating to low-grade inflammation.Type: ApplicationFiled: May 12, 2010Publication date: May 31, 2012Applicant: VALIO LTD.Inventor: Riina Kekkonen
-
Publication number: 20120135044Abstract: The present invention relates to the fields of hydration and nutrition for dysphagic patients. In particular, the present invention relates to thickeners comprising probiotic microorganisms and to compositions comprising such thickeners. The probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic microorganisms.Type: ApplicationFiled: May 11, 2010Publication date: May 31, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Patent number: 8187585Abstract: The present invention relates to a composition comprising at least one fibronectin binding protein, and/or at least one a truncated fibronectin binding protein and/or at least one fibronectin binding peptide, all comprising at least one fibronectin binding domain; and at least one iscom matrix complex and/or liposome and/or at least one lipid and at least one saponin, whereby the at least one lipid and the at least one saponin may be in complex, solution or suspension. Further, it regards use thereof for the preparation of a vaccine against a micro organism that comprises at least one fibronectin binding domain. It also relates to a kit of parts comprising at least two compartments, wherein one compartment comprises at least one truncated fibronectin binding protein and/or a fibronectin binding peptide, that comprises at least one fibronectin binding domain, and another compartment comprises an instruction for use and/or an iscom matrix complex and/or an iscom complex and or a liposome.Type: GrantFiled: July 20, 2011Date of Patent: May 29, 2012Assignee: Isconova ABInventors: Bror Morein, Karin Lövgren Bengtsson, Jill Ekstrom, Katarina Ranlund, Birgitta Fromgren, Carlos Concha Bascunan
-
Publication number: 20120128644Abstract: The invention provides methods for treating respiratory infections by administering compositions comprising one or more isolated, non-pathogenic, hydrogen peroxide-producing bacterial species or strains to the mouth, oropharynx, larynx, nasal cavity, fauces of a subject.Type: ApplicationFiled: November 22, 2011Publication date: May 24, 2012Inventor: Jeffrey D. Hillman
-
Publication number: 20120128594Abstract: The present invention relates to bacteria which specifically target infracted tissue and use thereof. The present invention provides a selective infracted tissue-targeting bacterium for the first time, and can be used in selectively delivering drugs to the infracted tissue or in selectively imaging the infracted tissue. The infracted tissue-targeting bacterium of the present invention can finish treatments by using antibiotics, and therefore, have remarkable advantages as compared to gene therapy using recombinant viruses. The infracted tissue-targeting bacterium of the present invention have a significantly high affinity and specificity to infracted myocardium or infracted brain, thereby significantly reducing undesired transfections in the organs or tissues other than the heart. The gene expression by the infracted tissue-targeting bacterium of the present invention in infracted myocardium or infracted brain is remotely controllable.Type: ApplicationFiled: May 27, 2010Publication date: May 24, 2012Applicant: INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITYInventors: Hyon El Choy, Jung-Joon Min, Hyung Seok Kim, Yeongjin Hong
-
Publication number: 20120128726Abstract: The present invention relates to the field of infant nutrition. In particular, the present invention relates to infant feeding formulas comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example.Type: ApplicationFiled: May 11, 2010Publication date: May 24, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120121652Abstract: The present invention relates to the field of nutrition for children. In particular, the present invention relates to the nutritional compositions intended for children with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to children with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms.Type: ApplicationFiled: May 11, 2010Publication date: May 17, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120121562Abstract: The present invention relates to a nutritional supplement compositions for breast-fed infants or pets which comprise at least one probiotic and at least one nutrient. The compositions are aimed at preserving exclusive breast feeding in infants. The compositions of the invention are also for use in improving the health of breast-fed infants. A method of preparing a nutritional supplement composition for breast-fed infants is also provided.Type: ApplicationFiled: July 28, 2010Publication date: May 17, 2012Applicant: NESTEC S.A.Inventors: Gabriela Bergonzelli Degonda, Isabelle Bureau-Franz, Clara Lucia Garcia-Rodenas, Corinne Magliola
-
Publication number: 20120121685Abstract: The present invention relates to the field of nutrition. In particular, the present invention relates to a breakfast cereal composition comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example.Type: ApplicationFiled: May 11, 2010Publication date: May 17, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120121561Abstract: The present invention relates to the field of nutrition for young children. In particular, the present invention relates to dry whole milk preparations comprising probiotic micro-organisms to be administered to young children older than 12 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example.Type: ApplicationFiled: May 11, 2010Publication date: May 17, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120114621Abstract: The disclosure relates to a solid glass matrix of polysaccharide, saccharides and polyols as delivery vehicles for preservation and post gastric administration of a probiotic. The delivery vehicle is capable of releasing the probiotic at their site of action. The present invention further includes methods of making and using the solid glass matrix delivery vehicle of the invention.Type: ApplicationFiled: January 17, 2012Publication date: May 10, 2012Inventors: MORDECHI HAREL, KEREN KOHAVI-BECK
-
Publication number: 20120114608Abstract: Disclosed herein are compositions for treating a respiratory condition, preferably by enhancing immune response in a mammal, the compositions including a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component. Also included are methods of treating a respiratory condition, preferably by enhancing immune response, in a mammal. Kits containing the compositions, and instructions for applying the methods are also included. The method includes orally administering to the mammal a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component.Type: ApplicationFiled: December 22, 2011Publication date: May 10, 2012Inventors: James Patrick Ebel, Lucy Anne Gildea, David Alexander Lawson, Jeffrey Warren Clymer
-
Publication number: 20120107287Abstract: The present invention relates to the field of specialized nutritional compositions. In particular, the present invention provides nutritional compositions for providing complete nutrition to hospitalized patients comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example.Type: ApplicationFiled: May 11, 2010Publication date: May 3, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120064051Abstract: The present invention relates to the field of infant and young children nutrition. In particular, the present invention relates to infant and young children feeding formulas comprising probiotic micro-organisms to be administered to infants and young children older than 6 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example.Type: ApplicationFiled: May 11, 2010Publication date: March 15, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120058095Abstract: The present invention refers to an oily suspension containing probiotic bacteria, particularly suitable for paediatric use.Type: ApplicationFiled: March 9, 2010Publication date: March 8, 2012Applicant: PROBIOTICAL S.p.A.Inventors: Gian Paolo Strozzi, Luca Mogna
-
Publication number: 20120039860Abstract: Compositions and methods for preventing and treating illnesses associated with oral health are provided. In a general embodiment, the compositions and methods of the present disclosure can improve oral health by reducing the incidence of aspiration pneumonia, community-acquired pneumonia and nosocomial pneumonia, allowing for less gingivitis and plaque, and providing improved tongue flora. By utilizing probiotics naturally present in the oral cavity or gastrointestinal tract, the compositions and methods in embodiments of the present disclosure can reduce anaerobic gram-negative bacilli and increase the presence of the normal flora. By preventing and treating problems associated with oral health in a patient, subsequent health problems can be prrevented or mitigated, which can result in reduced health care costs for the patient in the future.Type: ApplicationFiled: December 14, 2009Publication date: February 16, 2012Applicant: NESTEC S.A.Inventors: Zamzam Kabiry Roughead, Kala Marie Kaspar
-
Publication number: 20120034198Abstract: Processes and formulations for the administration and storage of dried microorganisms are disclosed. Microbial based products containing prebiotic formulations for administration and for storage of microorganisms are disclosed. These prebiotic formulations can act both for administration into an animal or human subject and act as to preserve or store the dried microorganisms.Type: ApplicationFiled: August 4, 2011Publication date: February 9, 2012Applicant: MICROBIOS, INC.Inventors: Matthew Ryan Garner, Joseph Flint
-
Publication number: 20120027735Abstract: The present invention relates to novel maple product compositions. In particular, the present invention relates to new compositions comprising maple sap, maple concentrate, maple syrup or diluted maple syrup, and probiotics, prebiotics or combinations thereof. The present invention also discloses methods for the production of maple based products, including functional drinks, comprising a composition comprising maple sap, maple concentrate, maple syrup or dilutated maple syrup, and probiotics, prebiotics or combinations thereof, as a vehicle for the delivery of probiotics and prebiotics to the gastrointestinal tract.Type: ApplicationFiled: March 5, 2010Publication date: February 2, 2012Applicant: Federation des producteurs acericoles du QuebecInventors: Geneviève Béland, Julie Barbeau, Ismail Fliss
-
Publication number: 20120027734Abstract: The present invention relates to butyrate producing bacterial strains related to the species Buty{acute over (?)}coccus pullicaecorum to be used in the prevention and/or treatment of intestinal health problems. The present invention therefore provides methods and compositions that overcome the problems associated with the currently used methods for administering butyric acid in the treatment of intestinal health problems in humans and/or animals.Type: ApplicationFiled: February 22, 2010Publication date: February 2, 2012Inventors: Filip Van Immerseel, Frank Pasmans, Richard Ducatelle, Benedikt Sas, Venessa Eeckhaut, Freddy Haesebrouck
-
Patent number: 8097245Abstract: The disclosure relates to a solid glass matrix of polysaccharide, saccharides and polyols as delivery vehicle for preservation and post gastric administration of a probiotic. The delivery vehicle is capable of releasing the probiotic at their site of action. The present invention further includes methods of making and using the solid glass matrix delivery vehicle of the invention.Type: GrantFiled: December 28, 2006Date of Patent: January 17, 2012Assignee: Advanced Bionutrition CorporationInventors: Mordechi Harel, Keren Kohavi-Beck
-
Publication number: 20120009163Abstract: An object of the present invention is to provide an effective means and method for activating vagal afferent nerve. The present invention provides a vagus nerve activator comprising bacterial cells and/or a treated product of a lactic acid bacteria as active ingredient(s).Type: ApplicationFiled: July 6, 2011Publication date: January 12, 2012Applicant: CALPIS CO., LTD.Inventors: Daisuke SAWADA, Shigeru FUJIWARA
-
Patent number: 8088369Abstract: The invention provides an anti-wrinkle agent which has an excellent effect of inhibiting the formation of wrinkles and excellent safeness. The anti-wrinkle agent contains, as an active ingredient, a culture supernatant of a lactic acid bacterium belonging to Streptococcus thermophilus.Type: GrantFiled: August 29, 2007Date of Patent: January 3, 2012Assignee: Kabushiki Kaisha Yakult HonshaInventors: Naoki Izawa, Ryoko Iizuka, Toshiro Sone, Katsuyoshi Chiba